Patents by Inventor Derek Hook

Derek Hook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8451121
    Abstract: A method for monitoring objects in a three dimensional target area and or business process decision making. The methods include calibration, recalibration, operation and rules compliance for a radio frequency object monitoring system. Location tags are placed throughout a three dimensional area in predetermined positions and used to determine relative position, movement and or distances of objects with and without object tags. Repeated scanning and comparison of data provides a database by which the object monitoring system responds according to predetermined rules.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: May 28, 2013
    Assignee: PF Controls, LLC
    Inventors: Christopher Derek Hook, Graham P. Bloy, Thomas Ellinwood, Christopher Gordon Gervase Turner
  • Publication number: 20110063113
    Abstract: A method for monitoring objects in a three dimensional target area and or business process decision making. The methods include calibration, recalibration, operation and rules compliance for a radio frequency object monitoring system. Location tags are placed throughout a three dimensional area in predetermined positions and used to determine relative position, movement and or distances of objects with and without object tags. Repeated scanning and comparison of data provides a database by which the object monitoring system responds according to predetermined rules.
    Type: Application
    Filed: September 9, 2010
    Publication date: March 17, 2011
    Applicant: RF CONTROLS, LLC
    Inventors: Christopher Derek Hook, Graham P. Bloy, Thomas Ellinwood, Christopher Gordon Gervase Turner
  • Publication number: 20070142399
    Abstract: Dual action compounds are provided that are inhibitors of catechol-omethyltransferase (COMT) enzyme and are also partial agonists or antagonists of the D2 receptor, or agonists of the D1 receptor, or interact in these ways with both D1 and D2 receptors. Use of the compounds for treating neuropsychiatric disorders, particularly schizophrenia and mild cognitive impairment, is also described.
    Type: Application
    Filed: June 21, 2004
    Publication date: June 21, 2007
    Applicant: Psychiatric Genomics, Inc.
    Inventors: Charles Altar, Malcolm Taylor, Derek Hook, Michael Palfreyman
  • Publication number: 20050181433
    Abstract: The present invention relates to screening methods and assays that are referred to herein as multi-parameter hight throughput screening (MPHTS) assays. These MPHTS assays are useful for identifying candidate pharmaceutical compounds. In particular, the screening methods of this invention may be used to identify compounds that have potential therapeutic benefits for the treatment of neuropscyhiatric and neurodegenerative disorders, including schizophrenia, bipolar affective disorder (BAD), autism and Alzheimer's disease to name a few.
    Type: Application
    Filed: April 4, 2005
    Publication date: August 18, 2005
    Applicant: Psychiatric Genomics, Inc.
    Inventors: C. Altar, Jeffrey Brockman, David Evans, Derek Hook, Leszek Klimczak, Pascal Laeng, Michael Palfreyman, Prithi Rajan
  • Publication number: 20030096264
    Abstract: The present invention relates to screening methods and assays that are referred to herein as multi-parameter hight throughput screening (MPHTS) assays. These MPHTS assays are useful for identifying candidate pharmaceutical compounds. In particular, the screening methods of this invention may be used to identify compounds that have potential therapeutic benefits for the treatment of neuropscyhiatric and neurodegenerative disorders, including schizophrenia, bipolar affective disorder (BAD), autism and Alzheimer's disease to name a few.
    Type: Application
    Filed: June 18, 2002
    Publication date: May 22, 2003
    Applicant: Psychiatric Genomics, Inc.
    Inventors: C. Anthony Altar, Jeffrey A. Brockman, David Evans, Derek Hook, Leszek J. Klimczak, Pascal Laeng, Michael Palfreyman, Prithi Rajan
  • Patent number: 5208364
    Abstract: Novel compounds derived from cultures of Streptomyces sp. AA2807 are useful as 5-lipoxygenase inhibitors.
    Type: Grant
    Filed: June 25, 1992
    Date of Patent: May 4, 1993
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Hiroaki Ohkuma, Yutaka Hoshino, Yosuke Sawada, Derek Hook